Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology.
Saved in:
| Title: | Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology. |
|---|---|
| Authors: | Spaan M; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van den Belt-Dusebout AW; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Lambalk CB; Department of Obstetrics & Gynecology, Amsterdam University Medical Center (UMC) Location, VU University Medical Center, Amsterdam, the Netherlands., van Boven HH; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Schats R; Department of Obstetrics & Gynecology, Amsterdam University Medical Center (UMC) Location, VU University Medical Center, Amsterdam, the Netherlands., Kortman M; Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, Utrecht, the Netherlands., Broekmans FJM; Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, Utrecht, the Netherlands., Laven JSE; Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Erasmus Medical Center, Rotterdam, the Netherlands., van Santbrink EJP; Department of Reproductive Medicine, Reinier de Graaf Hospital, Voorburg, the Netherlands., Braat DDM; Department of Obstetrics and Gynecology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands., van der Westerlaken LAJ; Department of Obstetrics, Gynecology and Reproductive Medicine, Leiden University Medical Center, Leiden, the Netherlands., Cohlen BJ; Department of Obstetrics and Gynecology, Isala Clinics, Zwolle, the Netherlands., Cantineau AEP; Department of Obstetrics and Gynecology, University Medical Center Groningen, University Groningen, Groningen, the Netherlands., Smeenk JMJ; Department of Obstetrics and Gynecology, St Elisabeth Hospital, Tilburg, the Netherlands., van Rumste MM; Department of Obstetrics and Gynecology, Catharina Hospital, Eindhoven, the Netherlands., Goddijn M; Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Amsterdam UMC Location, Academic Medical Center, Amsterdam, the Netherlands., van Golde RJT; Department of Obstetrics and Gynecology, Maastricht University Medical Center, Maastricht, the Netherlands., Meeuwissen PAM; Department of Obstetrics and Gynecology, Admiraal de Ruyter Hospital, Vlissingen, the Netherlands., Hamilton CJCM; Department of Obstetrics and Gynecology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, the Netherlands., Ouwens GM; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Gerritsma MA; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Schaapveld M; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Burger CW; Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Erasmus Medical Center, Rotterdam, the Netherlands., van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, the Netherlands. |
| Source: | Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jun 01; Vol. 113 (6), pp. 699-709. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1460-2105 |
|---|---|
| DOI: | 10.1093/jnci/djaa163 |
